Última Hora: "Emigrantes lesados do BES alertam turistas que ?Portugal não é o país que se pensa? - Observador" Sat, 29 Apr 2017 13:34:08 GMT    "Falências decretadas nos tribunais diminuem 16% no 4.º trimestre de 2016 - RTP" Sat, 29 Apr 2017 13:46:00 GMT    "Karoq. Este é o novo SUV compacto da Skoda - Observador" Sat, 29 Apr 2017 09:03:07 GMT    "Almaraz: MPT qualifica como "fraude" aprovação do ATI na central nuclear espanhola - Diário de Notícias - Lisboa" Sat, 29 Apr 2017 14:16:31 GMT    "United subiu oferta para 10 mil dólares em caso de ?overbooking? - RTP" Fri, 28 Apr 2017 10:24:05 GMT   "CGD: "Mal seria se não acreditasse na palavra do Governo" - Jornal de Negócios - Portugal" Fri, 28 Apr 2017 11:53:26 GMT    "Plano PS/BE com primeiro revés: Fundo de resgate diz que não pode baixar juros - Jornal de Negócios - Portugal" Fri, 28 Apr 2017 18:40:36 GMT    "Região Centro vista à lupa - Jornal de Negócios - Portugal" Fri, 28 Apr 2017 17:07:46 GMT    "PCP insiste numa "efetiva renegociação" da dívida pública - Diário de Notícias - Lisboa" Sat, 29 Apr 2017 16:42:32 GMT    "Comércio a retalho nogoceia menos em março do que em fevereiro, mas acima de 2016 - RTP" Fri, 28 Apr 2017 12:18:00 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Mostrar Notícias:
 Ver notícias de outros activos

Pesquisa de notícias relativas à acção Sepracor Inc. (ordenadas pela data):


Novelion Therapeutics (NVLN) Appoints Mark Corrigan to Board of Directors
StreetInsider.com
Dr. Corrigan was previously president and chief executive officer of Zalicus Inc. Prior to that, he was executive vice president, research & development of Sepracor Inc. (now Sunovion Pharmaceuticals). Prior to joining Sepracor, Dr. Corrigan spent 10 ...

e mais »

Rewire

Religious Imposition Proponents Find an Ally in the White House
Rewire
Stirrup worked as a senior legislative adviser at Venable LLP from 2003 to 2008. The firm's clients between those years included AstraZeneca Pharmaceuticals, Sepracor Inc, and the National Association of Spine Specialists. Another hire, Anna Pilato, is ...


Flex Pharma Names William K. McVicar, Ph.D. as President, Research & Development
Business Wire (press release)
Flex Pharma, Inc. (NASDAQ: FLKS), focused on developing treatments for cramps and spasms associated with severe neurological diseases, today announced the appointment of William K. McVicar, Ph.D., as President of Research and Development. ... ?With ...

e mais »

Overview of Consultation-Liaison Psychiatry: April 2017
Healio
Andrew A. Nierenberg, MD, has disclosed the following relevant financial relationships: Appliance Computing Inc. (Mindsite); Astra Zeneca; Brain Cells, Inc.; Brandeis University; Bristol Myers Squibb; Clintara, Dianippon Sumitomo/Sepracor; Eli Lilly ...


InvestorGuide

Cynapsus Therapeutics (CYNA) Stock Doubles on Sunovion Buyout
InvestorGuide
Shares of Cynapsus Therapeutics Inc. (CYNA) were trading up +21.44 or +116.78 percent to $39.80 per share in Thursday's premarket after news broke late yesterday that it would be acquired by Sunovion Pharmaceuticals Inc. Cynapsus Therapeutics stock ...

e mais »

Biotech Losers in Spotlight: Flex Pharma, Inc. (NASDAQ:FLKS), Nektar Therapeutics (NASDAQ:NKTR), Ritter ...
Benchmark Monitor
?With their successful partnership from their time at Sepracor, Bill and our CMO, Dr. Tom Wessel, are a great team to rapidly advance our Phase 2 clinical trials in MS, ALS and Charcot-Marie-Tooth with FLX-787 which will be amongst the most advanced ...

e mais »

Frequency Therapeutics Announces its Board of Directors and the Appointment of Marc A. Cohen as Chairman
Business Wire (press release)
The Board Members include Tim Barberich, founder and former CEO and Chairman of Sepracor, Inc. (now known as Sunovion), Marc Kozin, Senior Advisor and former President of L.E.K. Consulting, Robert S. Langer, Sc.D., Frequency Co-founder and the ...

e mais »

Sunovion Celebrates Five-Year Anniversary Milestone
Business Wire (press release)
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) announced today that it is celebrating its five-year anniversary. Sunovion was established in October 2010 following the integration of Sepracor Inc. and Dainippon ...

e mais »

Nabriva Announces Nomination of Candidates for Its Supervisory Board
GlobeNewswire (press release)
Dr. Corrigan is former President and Chief Executive Officer of Zalicus, Inc. Previously, Dr. Corrigan was Executive Vice President of Research and Development at the specialty pharmaceutical company Sepracor Inc., and prior to this, he spent 10 years ...

e mais »

Sunovion Pharmaceuticals Inc. Announces Company Name Change
Business Wire (press release)
BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion), formerly Sepracor Inc. (Sepracor), announced today that it has formally changed its name. The change occurs on approximately the one year anniversary of the acquisition of Sepracor by ...

e mais »

TheChronicleHerald.ca (registration)

PEI's BioVectra buys former Sepracor plant in Windsor
TheChronicleHerald.ca (registration)
A Charlottetown drug manufacturer has acquired a mothballed Windsor pharmaceutical plant and plans to reopen the facility in early 2016. BioVectra Inc. purchased the former Sepracor Canada (Nova Scotia) Ltd. facility in May. The Sepracor operation ...
Charlottetown's BioVectra expanding, setting up in WindsorHants Journal

todos os 5 artigos de notícias »

PMLiVE

Astellas appoints ethics and compliance and US legal leaders
PMLiVE
Wanda brings over 20 years of experience in the pharmaceutical industry, having held senior leadership positions at Schering-Plough and Sepracor Inc, a US-based biopharmaceutical company. Prior to joining Astellas as deputy general counsel and head of ...


POZEN Announces Retirement of Founder, Chairman and CEO Dr. John R. Plachetka; Adrian Adams Named as CEO
Business Wire (press release)
Prior to joining Sepracor, Mr. Adams was President and Chief Executive Officer of Kos Pharmaceuticals, Inc. until its acquisition by Abbott Laboratories. Mr. Adams has also held general management and senior international and national marketing ...

e mais »

Boston Globe

Sunovion gets OK for its epilepsy drug
Boston Globe
Marlborough biotech Sunovion Pharmaceuticals Inc. is preparing to start selling a new antiseizure pill early next year, following Food and Drug Administration approval of the medication. FDA regulators signed off on Sunovion's first epilepsy drug ...

e mais »

CoLucid Pharmaceuticals Announces Election of Mark Corrigan, MD, to Board of Directors
GlobeNewswire (press release)
Dr. Corrigan was Executive Vice President, Research & Development of Sunovion Pharmaceuticals Inc. (formerly Sepracor Inc.) from April 2003 until December 2009. Prior to joining Sunovion Pharmaceuticals, he spent 10 years with Pharmacia & Upjohn, Inc.

e mais »

Reuters

Dainippon to buy US drug firm Sepracor for $2.6 billion
Reuters
BOSTON/TOKYO Dainippon Sumitomo Pharma Co Ltd agreed on Thursday to buy U.S. drugmaker Sepracor Inc for $2.6 billion, giving the Japanese firm a big, local sales force in the world's largest drugs market. The deal is the latest in a string of overseas ...
Drugmaker Sepracor Accepts $2.6B Buyout Offer from Japan's DainipponXconomy

todos os 485 artigos de notícias »

Sunovion Pharmaceuticals Canada Inc. Announces Company Name Change
Canada NewsWire (press release)
Sepracor Pharmaceuticals, Inc. changes name, maintains commitment to developing scientifically-advanced central nervous system, cardiovascular disease and infectious disease therapies that improve patients' lives. MISSISSAUGA, ON, Aug. 17, 2011 ...

e mais »

CEO Adrian Adams Is Prepping Aralez For A Sale
Seeking Alpha
Aralez has an approval for Yosprala, a revenue-generating set of products, and two acquisitions that can make it money. Its bull thesis considers those as positives while the bear focuses on the debt that goes with the package. CEO Adrian Adams, with a ...


Crain's Detroit Business

Detroit-based Trimaran Pharma attracts experienced executives
Crain's Detroit Business
based Sepracor Inc. when it launched Lunesta, an insomnia drug that was later named by Forbes Magazine as the fifth most successful launch in pharma history, eventually surpassing $1 billion in annual sales. Piskorski also has startup experience.


Boston Globe

FDA approves Marlborough company's epilepsy drug
Boston Globe
An epilepsy tablet made by Marlborough-based Sunovion Pharmaceuticals Inc. won US approval Friday to be sold as a primary therapy for hundreds of thousands of Americans suffering from partial-onset seizures. The drug, called Aptiom, has been on the ...

e mais »

Adrian Adams named new CEO of Sepracor
Bizjournals.com
Before joining Sepracor, Adams had been the head of Kos Pharmaceuticals Inc., which was acquired in December by Abbott Laboratories for $3.7 billion. Adams' background includes research and development, sales, international and national product ...


Envisia Therapeutics Appoints William Yelle Executive Chairman
PR Newswire (press release)
Prior to Aldea, Yelle was Senior Vice President of Corporate Development for Sunovion Pharmaceuticals Inc. (formerly Sepracor Inc.). While at Sepracor, he was instrumental in the company's transition from an early stage clinical organization into a ...

e mais »

San Francisco Business Times (blog)

Can depression be treated like cancer? This startup thinks so
San Francisco Business Times (blog)
Uncovering ways that cancer exploits cellular weakness, researchers have discovered new treatments that attack those specific pathways. Now a Bay Area biotech startup wants to take that mindset to depression and other mental disorders. BlackThorn ...
BlackThorn Therapeutics Launches to Develop Novel, Targeted Treatments for Neurobehavioral DisordersBusiness Wire (press release)

todos os 7 artigos de notícias »

Kala Pharmaceuticals Appoints Mark Iwicki as Executive Chairman
Business Wire (press release)
BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (Kala), a developer of innovative ophthalmic products based on its proprietary mucus-penetrating particle (MPP) technology, today announced the appointment of Mark Iwicki as Executive Chairman and a ... Mr ...

e mais »

Medscape

Dietary Supplement Kit May Head Off Postpartum Blues
Medscape
A dietary supplement kit containing tryptophan, tyrosine, and blueberry juice/extract appears to markedly reduce vulnerability to postpartum blues (PPB), a new open-label study suggests. "The supplement taken on days 3 to 5 post partum had a very ...


Medscape

AAN Releases First Treatment Guideline on Restless Legs Syndrome
Medscape
The American Academy of Neurology (AAN) has released its first practice guideline for the management of restless legs syndrome (RLS) in adult patients. Medication, especially pramipexole (Mirapex, Boehringer Ingelheim), rotigotine (Neupro, UCB), and ...


Cincinnati.com

Healthwarehouse.com gets a new leader
Cincinnati.com
Florence-based online pharmacy HealthWarehouse.com Inc. has a new leader. John Pauly was appointed chief operating ... 12 years at pharmaceuticals company Sepracor. Before joining Sepracor, Pauly worked at Richwood Pharmaceuticals and Centocor.


Mylan, Sunovion Reach Terms In Xopenex Patent Fight
Law360 (subscription)
Law360, New York (May 29, 2012, 5:50 PM EDT) -- Mylan Inc. said Tuesday it had settled a patent fight with Sunovion Pharmaceuticals Inc. over the asthma drug Xopenex, in a deal that will allow Mylan to continue selling its own version of the drug and ...

e mais »

Ex-HR Consultant Avoids Prison For Inside Stock Tips
Law360 (subscription)
Law360, New York (March 15, 2016, 1:56 PM EDT) -- A former human resources consultant was sentenced in New York federal court on Tuesday to time served for passing inside information about pharmaceutical industry mergers to a film producer whose ...


Seeking Alpha

Aralez: Zigging When The Pharma Industry Is Zagging
Seeking Alpha
President and CEO of Sepracor, which was acquired by Dainippon Sumitomo Pharma in February 2010 for $2.6 billion. He oversaw multiple strategic activities at Sepracor, including in-licensing of seven products and some out-licensing deals. President and ...


Largura do Site:

 Imagem de Fundo:

Copyright@1998-2017 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters